Pepcid AC Disease Interactions
There are 2 disease interactions with Pepcid AC (famotidine).
H2 antagonists (applies to Pepcid AC) GI bleeding
Major Potential Hazard, Moderate plausibility. Applicable conditions: Gastrointestinal Hemorrhage
Histamine H2 receptor antagonists should not be used in the presence of vomit with blood, or bloody or black stools. These might be serious conditions and the diagnosis needs to be ruled out.
References (5)
- (2002) "Product Information. Pepcid (famotidine)." Merck & Co., Inc
- (2002) "Product Information. Axid (nizatidine)." Lilly, Eli and Company
- (2001) "Product Information. Tagamet (cimetidine)." SmithKline Beecham
- (2001) "Product Information. Tritec (ranitidine bismuth citrate)." Glaxo Wellcome
- (2002) "Product Information. Zantac 75 (ranitidine)." Pfizer U.S. Pharmaceuticals
Famotidine (applies to Pepcid AC) renal dysfunction
Moderate Potential Hazard, High plausibility.
Famotidine is partially eliminated by the kidney as unchanged drug, the extent of which is dependent upon the route of administration (25% to 30% oral; 65% to 70% intravenous). The elimination half-life of famotidine may be prolonged considerably in patients with severe renal impairment (CrCl < 10 mL/min), possibly exceeding 20 hours and approaching approximately 24 hours in anuric patients. Since central nervous system adverse effects such as grand mal seizures and psychic disturbances have been reported in patients with moderate (CrCl < 50 mL/min) and severe renal impairment, dosage adjustments are recommended for these patients. Reducing the normally recommended dosage by one-half or prolonging the dosing interval to 36 to 48 hours may be appropriate, depending on the patient's clinical response.
References (7)
- Halstenson CE, Abraham PA, Opsahl JA, Chremos AN, Keane WF, Matzke GR (1987) "Disposition of famotidine in renal insufficiency." J Clin Pharmacol, 27, p. 782-7
- Gladziwa U, Klotz U, Krishna DR, Schmitt H, Glockner WM, Mann H (1988) "Pharmacokinetics and dynamics of famotidine in patients with renal failure." Br J Clin Pharmacol, 26, p. 315-21
- Hachisu T, Yokoyama T, Oda Y, Ando K, Hattori Y, Yoshida T (1988) "Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure." Clin Ther, 10, p. 656-63
- Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Kawabata M, Hashimoto N, et al. (1985) "Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function." Eur J Clin Pharmacol, 28, p. 327-31
- Kroemer H, Klotz U (1987) "Pharmacokinetics of famotidine in man." Int J Clin Pharmacol Ther Toxicol, 25, p. 458-63
- (2002) "Product Information. Pepcid (famotidine)." Merck & Co., Inc
- Gladziwa U, Klotz U (1994) "Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure." Clin Pharmacokinet, 27, p. 393-408
Switch to consumer interaction data
Pepcid AC drug interactions
There are 314 drug interactions with Pepcid AC (famotidine).
Pepcid AC alcohol/food interactions
There is 1 alcohol/food interaction with Pepcid AC (famotidine).
More about Pepcid AC (famotidine)
- Pepcid AC consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: H2 antagonists
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Protonix
Protonix (pantoprazole) is used to treat erosive esophagitis and other conditions involving excess ...
Nexium
Nexium is used to treat GERD and other conditions involving excessive stomach acid. Learn about ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Pepcid
Pepcid is used to treat ulcers in the stomach and for conditions where the stomach produces too ...
Ranitidine
Ranitidine is used to treat and prevent ulcers in the stomach and intestines. Includes ranitidine ...
Lansoprazole
Lansoprazole is used to treat stomach and intestinal ulcers, erosive esophagitis and ...
Sucralfate
Sucralfate systemic is used for duodenal ulcer, duodenal ulcer prophylaxis, GERD, hyperphosphatemia ...
Esomeprazole
Esomeprazole systemic is used for barrett's esophagus, duodenal ulcer prophylaxis, erosive ...
Prilosec
Prilosec (omeprazole) is used to treat symptoms of GERD and other conditions caused by excess ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.